According to a study which is published in the journal of Science, results of early tests on a new experimental drug bring hope to men diagnosed with the most aggressive form of prostate cancer.
Ten percent of men diagnosed with prostate cancer have an aggressive form of the disease. The drug resistant form of the disease accounts for nearly all the 29,000 deaths among Americans every year.
In the study, the researchers showed that the new drug caused levels of the prostate specific antigen (PSA) to fall by at least 50% in 13 of 30 patients with advanced prostate cancer that had resisted other treatments.
Post a Comment to "New Prostate Cancer Drug Shows Promise"
To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."Berger & Lagnese, LLC
310 Grant Street
Suite 720
Pittsburgh, PA 15219
Phone: (412) 471-4300
Fax: (412) 471-3116
Toll Free: (800) 350-6161
Get Directions